Millions of AIDS patients "very poor" would die if India restricts the production of generic drugs against this sickness under the trade agreement with the European Union is currently negotiating , warned on Tuesday as the Joint United Nations Program for HIV-AIDS (UNAIDS).
In an interview with Reuters, the executive director of UNAIDS, Michel Sidibe, has warned that "millions will die if India can not produce" such cheap drugs and pointed to Africa "as the most affected" by this decision. The fact that about 86 percent of individuals treated for receiving AIDS drugs manufactured in India, says, makes this issue "in a matter of life or death." Therefore, Sidibé has explained, "India must resist to eliminate any flexibility, since any trade agreement that could lead to India" to limit their production capacity, will have "dire" consequences "for the rest of the world." India and EU are trading at today, a free trade agreement.
In an interview with Reuters, the executive director of UNAIDS, Michel Sidibe, has warned that "millions will die if India can not produce" such cheap drugs and pointed to Africa "as the most affected" by this decision. The fact that about 86 percent of individuals treated for receiving AIDS drugs manufactured in India, says, makes this issue "in a matter of life or death." Therefore, Sidibé has explained, "India must resist to eliminate any flexibility, since any trade agreement that could lead to India" to limit their production capacity, will have "dire" consequences "for the rest of the world." India and EU are trading at today, a free trade agreement.